Literature DB >> 19671913

Aspirin as adjuvant therapy for colorectal cancer: a promising new twist for an old drug.

Alfred I Neugut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19671913     DOI： 10.1001/jama.2009.1145

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Mechanisms in clinical practice: use and justification.

Authors:  Mark R Tonelli; Jon Williamson
Journal:  Med Health Care Philos       Date:  2020-03

2.  PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.

Authors:  Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Wolfram Goessling; Andrew T Chan; Kimmie Ng; Jennifer A Chan; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

Review 3.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Authors:  S Ogino; P Lochhead; E Giovannucci; J A Meyerhardt; C S Fuchs; A T Chan
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

4.  Use of aspirin postdiagnosis improves survival for colon cancer patients.

Authors:  E Bastiaannet; K Sampieri; O M Dekkers; A J M de Craen; M P P van Herk-Sukel; V Lemmens; C B M van den Broek; J W Coebergh; R M C Herings; C J H van de Velde; R Fodde; G J Liefers
Journal:  Br J Cancer       Date:  2012-03-27       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.